|
1
|
Bertram L and Tanzi RE: The genetic
epidemiology of neurodegenerative disease. J Clin Invest.
115:1449–1457. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wirdefeldt K, Adami HO, Cole P,
Trichopoulos D and Mandel J: Epidemiology and etiology of
Parkinson's disease: A review of the evidence. Eur J Epidemiol. 26
Suppl 1:S1–S58. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Irizarry MC, Growdon W, Gomez-Isla T,
Newell K, George JM, Clayton DF and Hyman BT: Nigral and cortical
Lewy bodies and dystrophic nigral neurites in Parkinson's disease
and cortical Lewy body disease contain alpha-synuclein
immunoreactivity. J Neuropathol Exp Neurol. 57:334–337. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Spillantini MG, Crowther RA, Jakes R,
Hasegawa M and Goedert M: Alpha-Synuclein in filamentous inclusions
of Lewy bodies from Parkinson's disease and dementia with lewy
bodies. Proc Natl Acad Sci USA. 95:pp. 6469–6473. 1998; View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Jellinger KA: Neuropathology of sporadic
Parkinson's disease: Evaluation and changes of concepts. Mov
Disord. 27:8–30. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ueda K, Fukushima H, Masliah E, Xia Y,
Iwai A, Yoshimoto M, Otero DA, Kondo J, Ihara Y and Saitoh T:
Molecular cloning of cDNA encoding an unrecognized component of
amyloid in Alzheimer disease. Proc Natl Acad Sci USA. 90:pp.
11282–11286. 1993; View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Jakes R, Spillantini MG and Goedert M:
Identification of two distinct synucleins from human brain. Febs
Lett. 345:27–32. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bartels T, Choi JG and Selkoe DJ:
α-Synuclein occurs physiologically as a helically folded tetramer
that resists aggregation. Nature. 477:107–110. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Mueller A, Ziegler K, Amsharov KY and
Jansen M: Perchloropyracylene and its fusion with C60 by
chlorine-assisted radio-frequency furnace synthesis. Chemistry.
17:11797–11804. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Eichner T and Radford SE: A diversity of
assembly mechanisms of a generic amyloid fold. Mol Cell. 43:8–18.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kruger R, Kuhn W, Müller T, Woitalla D,
Graeber M, Kösel S, Przuntek H, Epplen JT, Schöls L and Riess O:
Ala30Pro mutation in the gene encoding alpha-synuclein in
Parkinson's disease. Nat Genet. 18:106–108. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chartier-Harlin MC, Kachergus J, Roumier
C, Mouroux V, Douay X, Lincoln S, Levecque C, Larvor L, Andrieux J,
Hulihan M, et al: Alpha-synuclein locus duplication as a cause of
familial Parkinson's disease. Lancet. 364:1167–1169. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Singleton AB, Farrer M, Johnson J,
Singleton A, Hague S, Kachergus J, Hulihan M, Peuralinna T, Dutra
A, Nussbaum R, et al: Alpha-Synuclein locus triplication causes
Parkinson's disease. Science. 302:8412003. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Alvarez-Erviti L, Seow Y, Schapira AH,
Rodriguez-Oroz MC, Obeso JA and Cooper JM: Influence of microRNA
deregulation on chaperone-mediated autophagy and α-synuclein
pathology in Parkinson's disease. Cell Death Dis. 4:e5452013.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Cuervo AM, Stefanis L, Fredenburg R,
Lansbury PT and Sulzer D: Impaired degradation of mutant
alpha-synuclein by chaperone-mediated autophagy. Science.
305:1292–1295. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Alvarez-Erviti L, Rodriguez-Oroz MC,
Cooper JM, Caballero C, Ferrer I, Obeso JA and Schapira AH:
Chaperone-mediated autophagy markers in Parkinson disease brains.
Arch Neurol. 67:1464–1472. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wacker JL, Zareie MH, Fong H, Sarikaya M
and Muchowski PJ: Hsp70 and Hsp40 attenuate formation of spherical
and annular polyglutamine oligomers by partitioning monomer. Nat
Struct Mol Biol. 11:1215–1222. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
Periquet M, Fulga T, Myllykangas L,
Schlossmacher MG and Feany MB: Aggregated alpha-synuclein mediates
dopaminergic neurotoxicity in vivo. J Neurosci. 27:3338–3346. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Auluck PK, Chan HY, Trojanowski JQ, Lee VM
and Bonini NM: Chaperone suppression of alpha-synuclein toxicity in
a Drosophila model for Parkinson's disease. Science. 295:865–868.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Klucken J, Shin Y, Masliah E, Hyman BT and
McLean PJ: Hsp70 reduces alpha-synuclein aggregation and toxicity.
J Biol Chem. 279:25497–25502. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Luk KC, Mills IP, Trojanowski JQ and Lee
VM: Interactions between Hsp70 and the hydrophobic core of
alpha-synuclein inhibit fibril assembly. Biochemistry.
47:12614–12625. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang R, Zhao J, Zhang J, Liu W, Zhao M, Li
J, Lv J and Li Y: Effect of lysosomal and ubiquitin-proteasome
system dysfunction on the abnormal aggregation of α-synuclein in
PC12 cells. Exp Ther Med. 9:2088–2094. 2015.PubMed/NCBI
|
|
23
|
Weissman AM: Themes and variations on
ubiquitylation. Nat Rev Mol Cell Biol. 2:169–178. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Davies SE, Hallett PJ, Moens T, Smith G,
Mangano E, Kim HT, Goldberg AL, Liu JL, Isacson O and Tofaris GK:
Enhanced ubiquitin-dependent degradation by Nedd4 protects against
α-synuclein accumulation and toxicity in animal models of
Parkinson's disease. Neurobiol Dis. 64:79–87. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Morrison AL, Dinges M, Singleton KD, Odoms
K, Wong HR and Wischmeyer PE: Glutamine's protection against
cellular injury is dependent on heat shock factor-1. Am J Physiol
Cell Physiol. 290:C1625–C1632. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Singleton KD and Wischmeyer PE:
Glutamine's protection against sepsis and lung injury is dependent
on heat shock protein 70 expression. Am J Physiol Regul Integr Comp
Physiol. 292:R1839–R1845. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yang J, Zhang Y, Zhao S, Zhang Z, Tong X,
Wei F and Lu Z: Heat shock protein 70 induction by glutamine
increases the alphasynuclein degradation in SHSY5Y neuroblastoma
cells. Mol Med Rep. 12:5524–5530. 2015.PubMed/NCBI
|
|
29
|
Zhang J, Liu B, Li J, Zhang L, Wang Y,
Zheng H, Lu M and Chen J: Hsf and Hsp gene families in Populus:
Genome-wide identification, organization and correlated expression
during development and in stress responses. BMC Genomics.
16:1812015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
McNaught KS, Belizaire R, Jenner P, Olanow
CW and Isacson O: Selective loss of 20S proteasome alpha-subunits
in the substantia nigra pars compacta in Parkinson's disease.
Neurosci Lett. 326:155–158. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
McNaught KS, Belizaire R, Isacson O,
Jenner P and Olanow CW: Altered proteasomal function in sporadic
Parkinson's disease. Exp Neurol. 179:38–46. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Song Y and Masison DC: Independent
regulation of Hsp70 and Hsp90 chaperones by Hsp70/Hsp90-organizing
protein Sti1 (Hop1). J Biol Chem. 280:34178–34185. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Fukayama S, Lanske B, Guo J, Kronenberg HM
and Bringhurst FR: Regulation of HSP70 by PTH: A model of gene
regulation not mediated by changes in cAMP levels. Am J Physiol.
271:C121–C129. 1996.PubMed/NCBI
|
|
34
|
Jacquier-Sarlin MR, Jornot L and Polla BS:
Differential expression and regulation of hsp70 and hsp90 by
phorbol esters and heat shock. J Biol Chem. 270:14094–14099. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wischmeyer PE, Kahana M, Wolfson R, Ren H,
Musch MM and Chang EB: Glutamine induces heat shock protein and
protects against endotoxin shock in the rat. J Appl Physiol (1985).
90:2403–2410. 2001.PubMed/NCBI
|
|
36
|
Singleton KD, Serkova N, Beckey VE and
Wischmeyer PE: Glutamine attenuates lung injury and improves
survival after sepsis: Role of enhanced heat shock protein
expression. Crit Care Med. 33:1206–1213. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Banerjee K, Munshi S, Sen O, Pramanik V,
Roy MT and Chakrabarti S: Dopamine cytotoxicity involves both
oxidative and nonoxidative pathways in SH-SY5Y cells: Potential
role of alpha-synuclein overexpression and proteasomal inhibition
in the etiopathogenesis of Parkinson's disease. Parkinsons Dis.
2014:8789352014.PubMed/NCBI
|
|
38
|
Zhou W, Hurlbert MS, Schaack J, Prasad KN
and Freed CR: Overexpression of human alpha-synuclein causes
dopamine neuron death in rat primary culture and immortalized
mesencephalon-derived cells. Brain Res. 866:33–43. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Bisaglia M, Greggio E, Maric D, Miller DW,
Cookson MR and Bubacco L: Alpha-synuclein overexpression increases
dopamine toxicity in BE2-M17 cells. BMC Neurosci. 11:412010.
View Article : Google Scholar : PubMed/NCBI
|
